July 21, 2025

Resistance to Bedaquiline Impacts TB Survival

A cohort study found that patients with bedaquiline-resistant tuberculosis had delayed microbiologic recovery, higher rates of treatment failure, and reduced tuberculosis-free survival at 18 months compared with those with bedaquiline-susceptible disease.

Conexiant

July 21, 2025

Stanford Physician-Scientist Takes CDER Helm

Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs.

Conexiant

July 21, 2025

Sharp Rise in Fentanyl Overdoses During Pandemic

From 2019 to 2021, U.S. emergency departments saw a 125.4% rise in synthetic opioid overdoses, highlighting shifting trends in hospital use related to opioids during and before the COVID-19 pandemic.

Conexiant

July 21, 2025

Tracking Meningitis, From Days to Years

Patients from the MeninGene study contributed serum samples over 5 years, revealing that autoimmune processes rarely drive long-term cognitive problems after bacterial meningitis.

Conexiant

July 17, 2025

FDA Approves Shingrix Prefilled Syringe Option

The FDA has approved a new prefilled syringe presentation of Shingrix to simplify herpes zoster vaccination for eligible adult patients.

Conexiant

July 17, 2025

Metformin Ineffective for COVID Recovery, Trial Finds

Researchers found metformin did not significantly shorten COVID-19 symptom duration in low-risk outpatients, though it was safe and well tolerated.

Conexiant

July 17, 2025

Cancer History Linked to Severe COVID-19, Study 

Adult childhood cancer survivors had a higher risk of severe COVID-19 despite lower infection rates and higher vaccination coverage.

Conexiant

July 16, 2025

Pandemic-Era Dog Acquisition Linked to Later Well-Being Decline

In a small sample, dog acquisition during the COVID-19 pandemic was linked to a brief rise in cheerfulness, followed by potential declines in well-being, with effects varying by caregiving role and measure.

Conexiant

July 14, 2025

Potential Links Between Infection and Alzheimer’s Disease

Researchers examine the potential contribution of Chlamydia pneumoniae and SARS-CoV-2 infections to Alzheimer’s disease pathogenesis, focusing on neuroinflammatory mechanisms and genetic factors such as APOEε4.

Conexiant